» Articles » PMID: 5041611

Absence of Circulating Antibodies to Carcinoembryonic Antigen in Patients with Gastrointestinal Malignancies

Overview
Journal Int J Cancer
Specialty Oncology
Date 1972 Mar 15
PMID 5041611
Citations 17
Authors
Affiliations
Soon will be listed here.
Citing Articles

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Zbar A, Lemoine N, Wadhwa M, Thomas H, Snary D, Kmiot W Br J Cancer. 1998; 77(5):683-93.

PMID: 9514045 PMC: 2149974. DOI: 10.1038/bjc.1998.114.


The presence of anti-carcinoembryonic antigen (CEA) antibodies in the sera of patients with gastrointestinal malignancies.

Konstadoulakis M, Syrigos K, Albanopoulos C, Mayers G, GOLEMATIS B J Clin Immunol. 1994; 14(5):310-3.

PMID: 7814460 DOI: 10.1007/BF01540984.


Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?.

Staab H, Anderer F, Stumpf E, Fischer R Br J Cancer. 1980; 42(1):26-33.

PMID: 7426328 PMC: 2010478. DOI: 10.1038/bjc.1980.199.


Rotter's node metastases. Therapeutic and prognostic considerations in early breast carcinoma.

Cody 3rd H, Egeli R, URBAN J Ann Surg. 1984; 199(3):266-70.

PMID: 6322707 PMC: 1353389. DOI: 10.1097/00000658-198403000-00003.


Studies of the association of the A, B and Lewis Blood group antigens with carcinoembryonic antigen (CEA).

Holburn A, Mach J, MacDonald D, Newlands M Immunology. 1974; 26(4):831-43.

PMID: 4859499 PMC: 1423179.